Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy

被引：0
|
作者：
Pearlman, Eugene [1 ]
Bibars, Wafi [2 ]
Willard, Jennifer [3 ]
Moore, Darlene [3 ]
机构：
[1] Vet Affairs Med Ctr, Memphis, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA
[3] Vet Affairs Med Ctr Memphis, Memphis, TN USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2015年 / 144卷
关键词：
D O I：
10.1093/ajcp/144.suppl2.127
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
127
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [1] Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy: Does the Prothrombin Time Matter?
    Pearlman, Eugene
    Singh, Harman
    Willard, Jennifer
    Moore, Darlene
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A128 - A128
  • [2] Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy
    Thalappil, Vijisha
    Anand, Jeyanthi
    Keepanasseril, Anish
    Kar, Rakhee
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 432 - 436
  • [3] Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
    Fuentes, Amaris
    Gordon-Burroughs, Sherilyn
    Hall, Jeffrey B.
    Putney, David R.
    Monsour, Howard P., Jr.
    [J]. THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 40 - 44
  • [4] Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment
    Moumneh, T.
    Mallecian, Y.
    Calmes, A.
    Lacour, E.
    Roy, P. M.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 360 - 361
  • [5] Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin
    Ratano, Damian
    Alberio, Lorenzo
    Delodder, Frederik
    Faouzi, Mohamed
    Berger, Mette M.
    [J]. THROMBOSIS RESEARCH, 2019, 175 : 53 - 58
  • [6] Comparing Activated Partial Thromboplastin Time and Heparin anti-Xa levels to monitor anticoagulant intensity of unfractionated heparin in Extracorporeal Membrane Oxygenation
    Dhillon, E.
    Laffan, M.
    Arachchillage, D. Jayakody
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 138 - 138
  • [7] Laboratory Monitoring of Heparin Therapy: Partial Thromboplastin Time or Anti-Xa Assay?
    Lehman, Christopher M.
    Frank, Elizabeth L.
    [J]. LABMEDICINE, 2009, 40 (01): : 47 - 51
  • [8] Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation
    Vandenbriele, C.
    Bhudia, N.
    Dhillon, E.
    Doyle, J.
    Laffan, M. A.
    Ledot, S.
    Morgan, C.
    Murfin, B.
    Passariello, M.
    Patel, B.
    Pepper, J.
    Price, S.
    Singh, S.
    Trimlett, R.
    Arachchillage, D. R. J.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 358 - 358
  • [9] Correlation of activated partial thromboplastin time versus anti-Xa levels for unfractionated heparin monitoring in postoperative pediatric liver transplant patients
    Brocks, Rebecca
    Lemoine, Caroline
    Brandt, Katherine
    Bhat, Rukhmi
    Superina, Riccardo
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26
  • [10] Comparison of 8 commercial Anti-Xa assays and the heparin assay by protamine titration in patients receiving unfractionated heparin
    Theaker, J
    Kitchen, S
    Philips, JK
    Preston, FE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1133 - P1133
12345